Back to Search
Start Over
Cardiac Magnetic Resonance in the Evaluation of COVID-19
- Source :
- Cardiac Failure Review, Vol 8, Iss , Pp - (2022)
- Publication Year :
- 2022
- Publisher :
- Radcliffe Medical Media, 2022.
-
Abstract
- Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populations after COVID-19, such as competitive athletes with a heightened risk of sudden cardiac death, patients with multisystem inflammatory syndrome, and people suspected of having COVID-19 vaccine-induced myocarditis. This review summarises the key attributes of CMR, reviews the literature that has emerged for using CMR for people who may have COVID-19-related complications after COVID-19, and offers expert opinion regarding future avenues of investigation and the importance of reporting findings.
- Subjects :
- Diseases of the circulatory (Cardiovascular) system
RC666-701
Subjects
Details
- Language :
- English
- ISSN :
- 20577559 and 20577540
- Volume :
- 8
- Issue :
- -
- Database :
- Directory of Open Access Journals
- Journal :
- Cardiac Failure Review
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4e8bcf08ffb04b299703ffd3f436e39c
- Document Type :
- article
- Full Text :
- https://doi.org/10.15420/cfr.2021.20